NCCN Foundation presents awards to young investigators

April 24, 2021

1 min read

ADD SUBJECT TO EMAIL NOTIFICATIONS

Receive an email when new articles are posted

Enter your email address to receive an email when new articles are posted to. “data-action =” subscribe “> Subscribe

We were unable to process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

Six young researchers received the NCCN Foundation Young Investigator Awards.

The recipients, all from institutions that are members of the National Comprehensive Cancer Network, will receive up to $ 150,000 for two years to advance their oncology research.

“NCCN is committed to improving the lives of people with cancer by supporting research that is new, transparent and meaningful,” Wui-Jin Koh, MD, NCCN’s chief medical officer, said in a press release. “The NCCN Foundation’s Young Investigator Awards program exemplifies this goal by nurturing emerging talent and exploring promising areas of study. Congratulations to all of the impressive researchers selected for these awards. “

The recipients and their research projects are:

Esra Akbay, PhD, from UT Southwestern Simmons Comprehensive Cancer Center – Activating anti-tumor innate immunity to overcome checkpoint block resistance in non-small cell lung cancer;
William C. Jackson, MD, from University of Michigan Rogel Cancer Center – A phase 2 randomized trial of moderate vs. ultra-hypofractionated post-prostatectomy radiation therapy;
Everett Moding, MD, PhD, from Stanford Cancer Institute – Resolving sarcoma evolution during tumor development and radiation therapy;
Neelima Navuluri, MD, MPH, from Duke Cancer Institute – Intervention Mapping to Improve Lung Cancer Screening Among Black Veterans;
Deborah Stephens, DO, from Huntsman Cancer Institute at the University of Utah – Non-melanoma skin cancer in patients with chronic lymphocytic leukemia: biology and prevention; and
Caitlin Zebley, MD, PhD, from St. Jude Children’s Research Hospital – Epigenetic reprogramming of chimeric antigen receptor T cell therapy.

The research of the six award winners will be presented at the NCCN Annual Conference in 2023.

“The recipients of the NCCN Foundation’s Young Investigator Award have contributed an impressive body of work over the years to improve quality, fairness, effectiveness and efficiency in cancer care, and we are pleased to continue this year,” Patrick Delaney, director of NCCN Foundation, said in the release. “We are curious how these prominent young researchers improve the results for the future [patients with cancer]. “

ADD SUBJECT TO EMAIL NOTIFICATIONS

Receive an email when new articles are posted

Enter your email address to receive an email when new articles are posted to. “data-action =” subscribe “> Subscribe

We were unable to process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

Comments are closed.